Health Resources & Services Administration Announces Initial Drugs for 340B Rebate Model Pilot Program
The US Health Resources and Services Administration (HRSA) has announced the initial nine drugs to be included in the 340B rebate model pilot program, set to begin on January 1, 2026.
The pilot program aims to evaluate a rebate-based framework for future drug pricing models amid ongoing industry litigation. According to HRSA, the program includes a select group of drugs from certain manufacturers who have submitted plans meeting specific criteria approved by HRSA.
The pilot program aims at assisting the development process for approving future models that are consistent with the 340B statute and Administration’s goals.
The decision comes after pharma companies filed suit regarding how 340B eligible hospitals should handle drug payments.
Author's summary: HRSA announces 9 drugs for 340B rebate pilot.
More News
- Donald Trump slams Seth Meyers again, calling him “The Least Talented Person on TV” | Al Bawaba
- How former Vancouver Canadians performed for the Blue Jays in the World Series
- Hema Malini Left Shocked When She Found Out About Shah Rukh Khan's Real Age, 'Thought He Must Be..'
- PSL club chairman: We're spending more money in this league
- Living Amid Bombs and Bloodshed, Painters in Gaza Hold Steadfast to Their Craft
- Why Millie Bobby Brown Accused Her 'Reel-Dad'? Did Netflix Launch An Inquiry Against David Harbour?
- Basic Education Department warns public against sharing false teacher verification claims
- John Travolta Proves He’s Still Got the Moves with a Legendary Dance Lesson on The Late Late Show
- Home record alive as Phoenix take down Wildcats
- Home record alive as Phoenix take down Wildcats